Experimental Hematology & Oncology
Title Abbreviation
Exp Hematol Oncol
Electronic ISSN
2162-3619
Readership
Biomedical Researchers, Clinicians, Hematologists, Oncologists, Pharmaco-Epidemiologists, Pharmacologists, Researchers, Scientists
Scope
Experimental Hematology & Oncology is an open access journal that encompasses all aspects of hematology and oncology with an emphasis on preclinical, basic, patient-oriented and translational research. The journal acts as an international platform for sharing laboratory findings in these areas and makes a deliberate effort to publish clinical trials with 'negative' results and basic science studies with provocative findings.
Experimental Hematology & Oncology publishes original work, hypothesis, commentaries and timely reviews. With open access and rapid turnaround time from submission to publication, the journal strives to be a hub for disseminating new knowledge and discussing controversial topics for both basic scientists and busy clinicians in the closely related fields of hematology and oncology.
Sponsoring Association(s)
No associations affiliated with this journal
Publisher Name
BioMed Central Ltd. (BMC)
To see more details about Experimental Hematology & Oncology,
Subscribe Now!
Impact Factor
JCR Categories/Rank
Electronic Circulation
Submission to Acceptance
Acceptance to Online Publication
Rejection Rate
Frequency
Journal Contact
Author Submission Guidelines